Schmid John P.
SEC Form 4 insider trading activity
Schmid John P. has filed 5 SEC Form 4 filings (7 transaction rows) across 3 companies, including BLSM, TRAX, ANAB, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Schmid John P. is listed as Director at BlossomHill Therapeutics, Inc. Inside the rolling window, Schmid John P. reported 1 open-market purchase totaling $96K in BLSM and 1 open-market sale totaling $1.2M in ANAB. The largest disclosed transaction in the window is a sale of 20,645 ANAB shares on Mar 30, 2026, worth $1.2M.
Companies traded
Other insiders at BLSM
Insider Buying
$96K
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Schmid John P. made?
Schmid John P. has filed 5 SEC Form 4 filings (7 transaction rows) across 3 companies, including BLSM, TRAX, ANAB since 2025.
Which companies does Schmid John P. trade?
Schmid John P. has filed SEC Form 4 disclosures for 3 companies, including BLSM, TRAX, ANAB.
When was Schmid John P.'s most recent SEC Form 4 filing?
Schmid John P.'s most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Schmid John P.'s total buy and sell value in the current window?
Inside the rolling retention window, Schmid John P. bought $96K and sold $1.2M based on SEC Form 4 filings.
What was Schmid John P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,645 ANAB shares on 2026-03-30, worth $1.2M, per SEC Form 4 filings.